Latest Period
Q1 2026
Security Snapshot
GLOBUS MEDICAL INC - Class A Stock (GMED) Institutional Ownership
CUSIP: 379577208
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
598
Shares (Excl. Options)
109,441,600
Price
$86.16
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Stock
- Symbol
- GMED on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 109,441,600
- Total 13F value
- $9,422,834,578
- Portfolio coverage rank
- 0.02%
- Share change
- -1,698,377
- Value change
- -$149,708,320
- Number of holders
- 598
- Shares outstanding
- 115,244,363
- SEC-reported price per share
- $90.03
- Insider filing price
- $90.03
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- GMED - GLOBUS MEDICAL INC - Class A Stock is tracked under CUSIP 379577208.
- 598 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 559 to 598 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $9,706,925,884 to $9,422,834,578.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 598 institutions filings for Q1 2026.
Security key
379577208
Latest holder period
Q1 2026
13F holders
598
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
GMED full holder history
GLOBUS MEDICAL INC SEC filings
GLOBUS MEDICAL INC company facts
GLOBUS MEDICAL INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 379577208:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
GMED
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 9.1% | +16% | $778,991,964 | -$11,095,352 | 10,487,237 | -1.4% | BlackRock, Inc. | 31 Mar 2025 |
| JANUS HENDERSON GROUP PLC | 6.1% | +5% | $522,135,958 | +$30,787,723 | 7,029,294 | +6.3% | JANUS HENDERSON GROUP PLC | 31 Mar 2025 |
As of 31 Mar 2026, 598 institutional investors reported holding 109,441,600 shares of GLOBUS MEDICAL INC - Class A Stock (GMED). This represents 95% of the company’s total 115,244,363 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
58%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.1% | 10,497,414 | +2.1% | 0.02% | $904,457,155 |
| JANUS HENDERSON GROUP PLC | 6.6% | 7,623,095 | +4.5% | 0.31% | $656,831,032 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 5,032,732 | 0% | 0.01% | $433,620,189 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.2% | 4,879,459 | 0% | 0.02% | $420,414,187 |
| Invesco Ltd. | 3.7% | 4,316,654 | +11% | 0.06% | $371,922,910 |
| STATE STREET CORP | 3.1% | 3,590,372 | +3.7% | 0.01% | $309,346,452 |
| Sculptor Capital LP | 2.7% | 3,058,000 | +1.9% | 3% | $263,477,280 |
| JPMORGAN CHASE & CO | 2.3% | 2,595,308 | -16% | 0.01% | $216,734,239 |
| BANK OF MONTREAL /CAN/ | 2% | 2,307,181 | -32% | 0.08% | $198,786,714 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 2,112,124 | +2.7% | 0.01% | $182,024,827 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.7% | 2,009,763 | -20% | 0.57% | $173,161,180 |
| CITADEL ADVISORS LLC | 1.7% | 1,966,114 | -23% | 0.12% | $169,400,382 |
| DIMENSIONAL FUND ADVISORS LP | 1.5% | 1,769,897 | +2% | 0.03% | $152,473,874 |
| GENEVA CAPITAL MANAGEMENT LLC | 1.5% | 1,760,971 | -7.4% | 3.2% | $151,725,238 |
| ALLIANCEBERNSTEIN L.P. | 1.5% | 1,750,832 | -5.1% | 0.05% | $152,865,142 |
| MILLENNIUM MANAGEMENT LLC | 1.4% | 1,643,352 | +601% | 0.11% | $141,591,208 |
| GW&K Investment Management, LLC | 1.3% | 1,494,723 | -1.4% | 1.1% | $128,786,000 |
| Boston Trust Walden Corp | 1.1% | 1,254,910 | -8.3% | 0.89% | $108,123,045 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.1% | 1,243,615 | +4.5% | 0.02% | $107,149,868 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.99% | 1,145,540 | +3.6% | 0.11% | $98,699,727 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.98% | 1,132,278 | +2.8% | 0.08% | $97,557,072 |
| GOLDMAN SACHS GROUP INC | 0.98% | 1,132,162 | +54% | 0.01% | $97,547,083 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 0.96% | 1,101,568 | +6.4% | 0.32% | $94,911,130 |
| MORGAN STANLEY | 0.92% | 1,060,500 | +15% | 0.01% | $91,372,829 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.79% | 912,905 | +107% | 0.04% | $78,655,895 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 109,441,600 | $9,422,834,578 | -$149,708,320 | $86.16 | 598 |
| 2025 Q4 | 111,087,022 | $9,706,925,884 | +$150,539,278 | $87.31 | 559 |
| 2025 Q3 | 115,933,964 | $6,654,707,679 | +$72,456,317 | $57.27 | 488 |
| 2025 Q2 | 114,075,801 | $6,730,550,265 | +$195,769,879 | $59.02 | 477 |
| 2025 Q1 | 109,345,858 | $7,997,914,722 | -$8,993,495 | $73.20 | 507 |
| 2024 Q4 | 108,904,887 | $9,007,980,911 | +$44,310,752 | $82.71 | 495 |
| 2024 Q3 | 108,072,594 | $7,734,964,942 | -$332,078,125 | $71.54 | 444 |
| 2024 Q2 | 112,764,178 | $7,722,959,830 | -$3,143,182 | $68.49 | 443 |
| 2024 Q1 | 113,402,229 | $6,082,679,016 | +$359,376,321 | $53.64 | 435 |
| 2023 Q4 | 106,692,854 | $5,685,431,048 | -$155,605,070 | $53.29 | 405 |
| 2023 Q3 | 109,414,808 | $5,433,176,387 | +$1,362,204,600 | $49.65 | 426 |
| 2023 Q2 | 81,374,906 | $4,843,899,307 | +$408,515,363 | $59.54 | 378 |
| 2023 Q1 | 74,600,238 | $4,224,726,594 | -$151,471,403 | $56.64 | 381 |
| 2022 Q4 | 75,948,098 | $5,639,196,814 | +$86,702,611 | $74.27 | 383 |
| 2022 Q3 | 74,451,382 | $4,436,437,568 | +$100,448,577 | $59.57 | 356 |
| 2022 Q2 | 72,222,203 | $4,054,750,490 | +$112,004,727 | $56.14 | 349 |
| 2022 Q1 | 69,530,797 | $5,130,106,470 | +$81,009,114 | $73.78 | 366 |
| 2021 Q4 | 68,345,177 | $4,935,105,853 | +$7,508,095 | $72.20 | 367 |
| 2021 Q3 | 67,700,811 | $5,190,187,299 | -$70,035,321 | $76.62 | 380 |
| 2021 Q2 | 68,045,932 | $5,276,020,366 | +$27,082,820 | $77.53 | 351 |
| 2021 Q1 | 67,739,467 | $4,178,223,997 | +$52,788,626 | $61.67 | 338 |
| 2020 Q4 | 66,616,139 | $4,344,582,646 | +$137,526,882 | $65.22 | 343 |
| 2020 Q3 | 64,418,606 | $3,189,910,125 | -$115,537,152 | $49.52 | 336 |
| 2020 Q2 | 66,705,847 | $3,180,329,751 | -$236,172,306 | $47.71 | 312 |
| 2020 Q1 | 71,806,963 | $3,053,523,816 | +$121,157,476 | $42.53 | 266 |